interferon-alfa-2b and ribavirin

DRUG2 trials

Sponsors

Kyoto University

Conditions

Hepatitis C, Chronic

Phase 4

Low-dose Peg-interferon Plus Ribavirin (IFN/RBV) for Prevention of Hepatocellular Carcinoma (HCC) Recurrence in Patients Who Had Surgery to Remove Primary HCC

CompletedNCT00375661

Kyoto UniversityHepatitis C, Chronic

Start: 2006-09-30End: 2013-03-31Updated: 2015-09-02

Unknown Phase

Comparative Trial of Standard Versus Low-dose Peg-Interferon Plus Ribavirin in the Treatment of Chronic Hepatitis C

CompletedNCT00216775

Kyoto UniversityHepatitis C, Chronic

Start: 2004-12-31End: 2008-05-31Updated: 2015-09-02